Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02628795 · ClinicalTrials.gov registry record · NA

Overcoming TWEAK Signaling to Restore Muscle and Mobility After Joint Replacement

A NA study of Osteoarthritis, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT02628795 is a NA study of Osteoarthritis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02628795, a NA study of Osteoarthritis, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This single-blind, randomized, controlled trial is designed to test the effect of an intensive, 16 week exercise rehabilitation program (progressive resistance training + functional mobility training) vs. usual care on restoration of muscle mass and mobility after total hip (THA) or knee (TKA) arthroplasty in men and women with end-stage osteoarthritis. The molecular basis underlying the trial is the presence of significant muscle inflammation susceptibility in many of these individuals, and the expectation that the more intensive intervention will overcome this inflammatory burden to facilitate recovery.

Conditions Studied

Interventions

  • OTHER Usual Care
  • BEHAVIORAL PRT + FM

Study Locations (1)

Alabama

  • UAB Center for Exercise Medicine - Birmingham

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2015-10
Est. Completion 2021-02-28
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02628795

The ClinicalTrials.gov registry entry for NCT02628795 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT02628795 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT02628795 about?

NCT02628795 is a clinical study titled "Overcoming TWEAK Signaling to Restore Muscle and Mobility After Joint Replacement". This single-blind, randomized, controlled trial is designed to test the effect of an intensive, 16 week exercise rehabilitation program (progressive resistance training + functional mobility training) vs. usual care on restoration of muscle mass and mobility after total hip (THA) or knee (TKA) arthr...

What is the current status of trial NCT02628795?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2015-10. Estimated completion is 2021-02-28.

What conditions does trial NCT02628795 study?

This clinical trial studies the following conditions: Osteoarthritis.

What interventions are being tested in trial NCT02628795?

The interventions under investigation include: Usual Care (OTHER), PRT + FM (BEHAVIORAL).

Who is sponsoring clinical trial NCT02628795?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02628795 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.